TC BIOPHARM HOLDINGS PLC (TCBPW)
Institutional ownership reported to the SEC as of Q4 2024, across 12 quarters.
5
Reporting holders
$9.2K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | $6.6K | 668,324 | 0.00% | new | NEW |
| Nantahala Capital Management, LLC | $2.3K | 235,294 | 0.00% | 12q | HELD |
| Csenge Advisory Group | $236 | 23,862 | 0.00% | 2q | +26.5% |
| UBS Group AG | $24 | 2,400 | 0.00% | 2q | +103.2% |
| Kepos Capital LP | $5 | 470,588 | 0.00% | 11q | HELD |
| ARMISTICE CAPITAL, LLC | $2 | 188 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 5 | $9.2K | 930,068 | 2 | 2 | 0 | 0.0% |
| Q3 2024 | 5 | $5.1K | 274,231 | 2 | 0 | 2 | 0.0% |
| Q2 2024 | 5 | $6.9K | 546,580 | 2 | 1 | 1 | 0.0% |
| Q1 2024 | 4 | $5.1K | 255,793 | 0 | 1 | 2 | 0.0% |
| Q4 2023 | 5 | $16.7K | 514,955 | 2 | 2 | 0 | 0.0% |
| Q3 2023 | 4 | $6.4K | 291,870 | 0 | 0 | 1 | 0.0% |
| Q2 2023 | 4 | $12.7K | 295,949 | 0 | 1 | 0 | 0.0% |
| Q1 2023 | 5 | $30.6K | 306,139 | 2 | 0 | 0 | 0.0% |
| Q4 2022 | 4 | $38.9K | 378,431 | 0 | 0 | 2 | 0.0% |
| Q3 2022 | 7 | $1.4M | 6,465,436 | 0 | 1 | 0 | 0.0% |
| Q2 2022 | 7 | $1.3M | 6,461,481 | 0 | 1 | 1 | 0.0% |
| Q1 2022 | 7 | $3.2M | 6,456,980 | 7 | 0 | 0 | 0.0% |